Skip to main content
DNA Labs India

CDHR1 Gene Cone-Rod Dystrophy Type 15 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

CDHR1 Gene Cone-Rod Dystrophy Type 15 NGS Genetic Test

Short Name: CDHR1 CORD15 NGS

Also known as: Cone-Rod Dystrophy 15 Genetic Test, CDHR1 Gene Sequencing, CORD15 NGS Test

CDHR1 Gene Cone-Rod Dystrophy Type 15 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are typically available within 3 to 4 weeks after sample collection.. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

To detect mutations in the CDHR1 gene associated with Cone-Rod Dystrophy Type 15, confirm a clinical diagnosis, assess carrier status, and guide genetic counseling and family planning.

Test Code
3814
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Reports are typically available within 3 to 4 weeks after sample collection.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation is required. Provide relevant clinical history and documentation if available.

Method: Venipuncture or Dried Blood Spot

Step 2

Laboratory Analysis

A blood sample will be drawn by a trained phlebotomist. If providing a saliva sample, follow the instructions on the collection kit. For FTA card, a drop of blood from a finger prick is collected.

Step 3

Report Delivery

You can resume normal activities immediately. Results are typically available within 3 to 4 weeks.

Timeline: Reports are typically available within 3 to 4 weeks after sample collection.

Patient Instructions

1
Before the Test:No special preparation needed. Prior genetic counseling is recommended.
2
During the Test:Sample collection takes only a few minutes. For blood sample, a vein in your arm will be used. For FTA card, a drop of blood from a finger prick is placed on the card.
3
After the Test:You can leave after sample collection. The laboratory will process your sample, and you will receive the report in 3-4 weeks.

About This Test

Who Should Get This Test

To detect mutations in the CDHR1 gene associated with Cone-Rod Dystrophy Type 15, confirm a clinical diagnosis, assess carrier status, and guide genetic counseling and family planning.

How to Prepare

  • No fasting required.
  • Maintain hydration before blood collection.
  • Please bring any prior medical records or genetic counseling report.

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Genetic testing for CDHR1-related cone-rod dystrophy can identify at-risk family members and provide crucial information for reproductive planning. We recommend that all patients undergo pre-test and post-test genetic counseling to fully understand the implications of their results."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
ContainerEDTA Vacutainer / FTA Card
Collection MethodVenipuncture or Dried Blood Spot

Sample Stability

Blood sample stable for 48 hours at 2-8°C
FTA card stable for at least 4 weeks at room temperature
Extracted DNA stable for longer periods at -20°C
Sample Rejection Criteria:
  • Hemolyzed blood sample
  • Inadequate sample quantity
  • Unlabelled or mislabelled sample
  • Improperly stored or transported sample

Understanding Your Results

The test result is interpreted in the context of clinical presentation, family history, and other diagnostic evaluations. Genetic testing does not predict the exact severity or rate of progression of cone-rod dystrophy.
📊

Negative (No pathogenic variant detected)

No disease-causing variant was found in the CDHR1 gene. A negative result does not completely exclude cone-rod dystrophy type 15, especially if clinical suspicion is high. Other genetic causes should be considered.

📊

Positive (Pathogenic variant detected)

A disease-causing variant was identified in the CDHR1 gene, confirming the clinical diagnosis of cone-rod dystrophy type 15. This result is informative for family studies and reproductive decisions.

📊

Variant of Unknown Significance (VUS)

A genetic variant was found whose significance is not yet clear. Additional testing of family members and further research may help classify the variant.

⚠️ When to Consult a Doctor:

Consult your ophthalmologist or medical geneticist if you experience visual symptoms such as progressive loss of central vision, night blindness, or difficulty with colors, especially if there is a family history of retinal dystrophy.

Limitations

  • NGS may not detect all types of mutations such as deep intronic variants or large structural rearrangements
  • Variant calling may require confirmation by Sanger sequencing
  • Test is specific to the CDHR1 gene and does not rule out other genetic causes of cone-rod dystrophy

Risks & Considerations

  • Minimal risk of bleeding or bruising at the injection site
  • Potential psychological impact from learning genetic status

Interfering Factors

  • Poor quality or degraded DNA
  • Sample contamination
  • Low DNA concentration
  • Large genomic rearrangements not detected by standard NGS

Frequently Asked Questions

What is the CDHR1 Gene Cone-Rod Dystrophy Type 15 NGS Genetic Test?
This test uses Next-Generation Sequencing to analyze the CDHR1 gene for mutations associated with Cone-Rod Dystrophy Type 15, an inherited retinal disorder. It helps confirm the clinical diagnosis and supports genetic counseling.
What does the CDHR1 gene do?
The CDHR1 gene provides instructions for making a protein called Cadherin-Related Family Member 1, which is important for the development and maintenance of photoreceptor cells in the retina.
Who should get this test?
Individuals with symptoms of cone-rod dystrophy, such as central vision loss, color vision problems, or night blindness, and those with a family history of the disorder are candidates for this test. It may also be used for genetic counseling.
What are the symptoms of cone-rod dystrophy type 15?
Common symptoms include progressive loss of central vision, difficulty distinguishing colors, night blindness, reduced visual acuity, and sensitivity to light.
How is this test performed?
A blood or saliva sample is collected. The sample is processed in the laboratory, and NGS technology is used to sequence the CDHR1 gene to detect any mutations.
What samples can be used for this test?
The test can be performed on a blood sample, extracted DNA, or a single drop of blood on an FTA card.
How long does the test take?
The test turnaround time is 3 to 4 weeks from the date the sample is received by the laboratory.
What is the cost of the test?
The CDHR1 Gene Cone-Rod Dystrophy Type 15 NGS Genetic Test costs INR 20,000 at DNA Labs India.
Does this test require fasting?
No, fasting is not required for this genetic test. You can eat and drink normally before sample collection.
What do positive test results mean?
A positive result means a disease-causing variant was found in the CDHR1 gene, confirming the molecular diagnosis of cone-rod dystrophy type 15. Genetic counseling is recommended.
Can this test be used for family planning decisions?
Yes, the results can help families understand the inheritance pattern and make informed decisions about family planning. Genetic counseling is recommended for all affected families.
Are home sample collection services available?
Yes, DNA Labs India offers free home sample collection for online bookings across major cities in India, including Mumbai, Delhi, Bangalore, Hyderabad, Chennai, and many more.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.